Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01915576 |
| Title | Phase I Dose Escalation Study With an Allosteric AKT 1/2 Inhibitor in Patients |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Bayer |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | FRA | DEU | CHE |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Santa Monica | California | 90404 | United States | Details | ||
| Boston | Massachusetts | 02215 | United States | Details | ||
| St. Louis | Missouri | 63110 | United States | Details | ||
| Houston | Texas | 77030 | United States | Details | ||
| Villejuif Cedex | 94805 | France | Details | |||
| Heidelberg | Baden-Württemberg | 69120 | Germany | Details | ||
| St. Gallen | Sankt Gallen | 9007 | Switzerland | Details |